ࡱ> Root EntryRoot EntryP(@#FileHeaderODocInfoAmBodyText`(`( HwpSummaryInformation.:PrvImage PrvTextSection0Sn !"#$%&'()*+,-./0123456789;<=>?@BCDEFGHIJKLMNPQRTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~2005Dij < } l r 0 : ˆX}ňHȭ ˆ XTY< r ‰0 : )ˆX}ňHȭ  HٳYP r <  }1 < : 80, ij, ଔ, ଧ͎, {, , e,  , } 1 : Diethofencarb, kresoxym-methyl, procymidone, triflumi- zole, vinclozollin, chlorothalonil, cypermethrin, fenvalerate, imidacloprid, pymetrozine, chlorfenapyr, dimethomorph, indoxacarb, difenoconazole, flufenoxuron r 8) < 8 - ׳< 3 L ij 1 ٳH <@ , @ X <\ 30 ٳH <\ ȴt 2 8 Pt < 8 - ׳< 3 L 1 ٳH Pt <\ ^tD 15, tD 15 ٳH 8 L < 8 - ׳< 3 L 1 ٳH L 8 Pt <\ ^tD 15, tD 15 ٳH 8 r l <̬)><ij }1X X( (%) ><Kresoxim -methyl><Procymidone><Triflumizole><Vinclozolin> < < 8><57.9><60.3><80.0><73.9> <Pt < 8><65.0><63.1><79.8><70.3> <L < 8><54.9><53.8><60.5><52.4> <8 ><59.3><59.1><73.4><65.5> <̬)><ଔ }1X X( (%) ><Kresoxim -methyl><Procymidone><Triflumizole> < < 8><43.4><44.3><63.4> <Pt < 8><65.0><65.5><64.1>GIF89atɻxxxkkk]]]PPPCCC555((( d`LH00`Hذ̘`H0|pdXL@`0H `H0`dHL`H0xp`XH@0d LȰ``HH00dLؘȀ`H0xp`XH@d0L `H0d`LH`H0|pdXL@0`$H`dHL00`HذȘdL0xp`XH@0` HdH0ȳ``HHdL0xp`XH@`0H Ը̰ĠऀؘpȈXxHp@h@d8`8X0xT0pH dxddxd`d`p`|``x`p``x`!,t H*\ȰÇ#JHŋ3jȱǏ CIɓ(S\ɲ˗0cʜI͛8sɳϟ@ F;jҥMB}J5TI:]:ueүL:lֲ]jkҫ'ۖ}T-׫OZzy LÈ+^U,صju,Y^{f$ఛ5,Zɦ;]#Cܚܿ\Q3ͻ 0i7FKQYdsOmuq[ٮX_Ͼˇ9=mUVtg&YxUٖ|v}\%lIhE[]ѕW}ΙVށf)jhԕYV_εl98@)Dxz&|IfT y~[P^)ݕc&gFhbXco(WtΤߊu)4vJj&Vqfc!~ glfuFRz%Le &[6j&&ꜧXڪW^+ z)Mqy*]5ZWj9&청^fzx 2knrȗLPNi 'ex9^jʭ 6Y*)>Ywbf'jՖp~<*yh)> ZoFz.2?!]ZƼ\sO熸ærf,(մnO.6g;"0"op-cvgh;_o+xi%&vQ)wLm/HyȀyrt}mf69V^ݍ=ʅd{/;`a``a`0} h $ L X dp Procymidone 112005D 1 4| T֔| $ 11:12:56user5, 7, 6, 3015 6@@@`(@k@ǿ^ۋx^OTviJނ(xՓ[WXxK=G^Qdd-}!d7oޛdnP7x6Jq4Mq)Q y YQ}2Cyc咀!,K Fw 5v[lI\@5ګX%dѬ$p}miIJ,.z̘DlX6ۛұ'O}ҼN@6){dfB{熴"~tԭ[O:I9 8/I%͟8sg;0!ZNrd.]&pgvN]I IQpc8 e4Վ),>QTg?P5t^zh=މ*-f Qޣ5s-CHtVjqX3I L<3hELμːo^ex8Z>"*;c#bmf7Hb\ +/:}5~6f_sZ֭cdm8F6~(w#+2k*D,.\6[Ұ%ئ崨v6tQe'5$崤Sv vrP촆8MSvFN[3k{ vbT04 l+Ƶ!(BFB!V7v 8RCB! TU~ DAk)Q HZxhC{ܙ;3Нxwfw{wà xThK@X1t7<>Ўg`qւSt_jLwdz W,.4b@DZ 6: h Є>0+x?#ͲW2m\G>9y}`x| o| ҩ,840g>뾴|9 C40hFD׃Hυ(%'6yOvx痩Ϝ52?;-~9 |znAv^c͛ෆ:f2bY@3]iGy@wqdzޣғӞQ3[|6q24?I3_g+Wn%ז fB?Y\٦tg^[s,V\W3{#nUʝxzc b-fEJ"0n @Fy|6 G <$q0ޏdbIx={ێElђۓ݇#P;M 9;ᡱ|/o!#1٣vA3јGYo+ y{=f} 2ć/m1_Ȝ7'f53&ޘ{B4=Ү)𕽪P[`aUix;w!voRߙw2-LWDQ_LYBwV"b|+-oΫߡ?PJ޼yfK|4uH}Hw;v'X13iYk ?bNn =ZXɽ6Q^0_?lɯҩ 8|n;~ *N٧>5 eЁ|0 ֲ=6a?)zNc*aN+9;6fC&2Fr 4:lDFn6F|W)J<TqoOH}!#Rb=n RIwBy#&М)GCc$61@s;@bUDMAևnwGWFj!,K=j1=o 0`x\pPܽ&EL=ɝ E׏򘴯*s[(VWqkeΑTv.hm#AP#YmnB(:џKs% )CFqGN+( E{H j;B¯NgFrE0Qdr41eQEB*Rjr^ m"Zjkc*=JNdr4QT[#\J9(*`#>*(GUQEvfDt**b)V8,z 򵕳/*=GUhM8ځޝgP+*&@(8ZW "YAPEc<$ 0zpτWP5x{ LSi׍)?#<Ձ;!ƪ#%+hލwzK}FF~7ڣ#VޗKXO@BpUX:Ou|װOUr:ەk/*r?ks> ٓk;brc`-T4Iu-[TL\_IxقSnZ8qD+FrbG4`J-:Z+6Nvb78Lbu0d]a(j ~G`H04 ETZ|M,)mw!8aClI1kat*O)mb QD\ TaԸRpW!}9.@NƍaW59aV uU.Qwe@D.(EXǬևE} .Hak\ Gu&>2-dG)(:E* ">[.cQBAAMP@°:{'J舌{J7숚0)ד1џUUro6cpLEf__86#f3[lVͦC0 x7 cO%m61$vJB9UǸJ<I_~X+xO7o쐐yN)ֹS,< 9BVڠ+d椌r4tB,qc*6ڑΈ Wuvѳ!eE+ZVcb'V䢩?s%=2|qԎ҅Z)Ӑ`c>6£ E|;T^x0p?1 yspĒjEAݩv('Tq59)XbmG>!*:)Xbmu\Z㘕Uܫ۟'ľϝHV^ԑ: dW_F9ckk:''٦"q1+{z-&h`ĔIV/a8 z7ugϊ.QzqMia: ÈgڇX;\:rֹ iLRYU!Uk'שX'Eu3l)b+#π+xW IϠA2j?& \2r.2Mp+Fle:EתO5 -FF^ΆEm`r4 b; bť JcoB<^GZq'V;iu